Human Psychopharmacology
Overview
Human Psychopharmacology is a peer-reviewed journal that focuses on the study of the effects of drugs on human behavior and cognition. It covers a wide range of topics including clinical trials, neuropharmacology, psychopharmacotherapy, and the impact of substances on mental health. The journal provides valuable insights into the field of psychopharmacology, aiding researchers, clinicians, and policymakers in understanding the effects and potential applications of various drugs on human psychology.
Details
Details
Abbr.
Hum Psychopharmacol
Start
1986
End
Continuing
Frequency
8 no. a year, 1998-
p-ISSN
0885-6222
e-ISSN
1099-1077
Country
United Kingdom
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 3937
86
SJR / Ranks: 8329
541
CiteScore / Ranks: 7822
3.40
JIF / Ranks: 5746
1.7
Recent Articles
1.
Pelizza L, Di Lisi A, Leuci E, Quattrone E, Palmisano D, Pupo S, et al.
Hum Psychopharmacol
. 2025 Feb;
40(2):e70003.
PMID: 39962036
Objective: Despite various models examining baseline factors, predicting outcomes in individuals at clinical high risk for psychosis (CHR-P) remains challenging. Specifically, neglecting factors like ongoing antipsychotic (AP) medications introduce bias...
2.
Aitken B, Downey L, Rose S, Manning B, Arkell T, Shiferaw B, et al.
Hum Psychopharmacol
. 2025 Feb;
40(2):e70002.
PMID: 39930713
Objective: To examine the effect of a low dose (10 mg) of methylphenidate on cognitive performance, visuospatial working memory (VSWM) and gaze behaviour capabilities in healthy adults. Methods: This randomised,...
3.
Merlo A, Koyun A, Hendriksen P, Garssen J, Bruce G, Stock A, et al.
Hum Psychopharmacol
. 2025 Jan;
40(2):e70000.
PMID: 39887587
Objective: This study investigated the impact of 2019 coronavirus disease (COVID-19) lockdowns on alcohol consumption and smoking behavior among young adults from Germany. Methods: An online survey was completed by...
4.
Cavalli J, Cuttler C, Cservenka A
Hum Psychopharmacol
. 2024 Dec;
40(1):e2915.
PMID: 39731518
Objective: Despite the popular public perception that cannabis use may be beneficial for relieving mental health symptoms, the empirical evidence remains equivocal. Various legal hurdles limit the ability to research...
5.
6.
Barquera J, De La Garza Garcia L, Sanchez-Torres G, Gogeascoechea-Hernandez A, Martinez S, Porras-Garza G, et al.
Hum Psychopharmacol
. 2024 Dec;
40(1):e2914.
PMID: 39665501
Objective: To evaluate agomelatine treatment in elderly patients with major depressive disorder (MDD) who developed hyponatremia while using selective serotonin receptor inhibitors (SSRIs). Methods: Patients (60 years or older) with...
7.
Ahmed S, Chaplin K, Young R, Deslandes P
Hum Psychopharmacol
. 2024 Nov;
39(6):e2912.
PMID: 39511954
Objective: This study investigated prescribing patterns of two cohorts of patients treated with selective serotonin reuptake inhibitors (SSRI) in primary care in Wales (UK), to better understand drivers for increased...
8.
Emre S, Asli S, Sener M, Eker S, Esma S
Hum Psychopharmacol
. 2024 Nov;
39(6):e2913.
PMID: 39511900
Objective: To define the impact of obesity on inflammatory and oxidative disturbances in antipsychotic-treated schizophrenia patients. Methods: Several cytokines, inflammatory, metabolic, and oxidative status markers were evaluated in obese (n ...
9.
Fatima K, Malik J, Muskan F, Raza G, Waseem A, Shahid H, et al.
Hum Psychopharmacol
. 2024 Jul;
39(6):e2911.
PMID: 39083548
Objective: Despite the historical neurological use of Withania somnifera, limited evidence supports its efficacy for conditions like anxiety and insomnia. Given its known anti-stress properties, this review evaluated its safety...
10.
Kammerer W
Hum Psychopharmacol
. 2024 Jul;
39(6):e2910.
PMID: 39024047
Objective: To compare the pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine (LDX). Methods: A search of Medline and Embase was conducted to identify relevant articles for this literature...